21 completed, 5 recruiting, 5 withdrawn, 2 unknown. 35 Phase 2, 5 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 35 | Completed 21, Recruiting 5, Withdrawn 5, Unknown 2, Suspended 1, Terminated 1 |
| Phase 1 | 5 | Recruiting 3, Completed 2 |
| Phase 3 | 4 | Completed 3, Terminated 1 |
Follow Arginine: new trials by email Literature Review of Arginine trials Research Report on Arginine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis | Phase 1 / Phase 2 | Recruiting | David K Carroll | 60 | 2025-12-19 | 2026-02-12 |
| RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography - Recurrent Meningioma | Phase 1 / Phase 2 | Recruiting | Joshua Palmer | 30 | 2025-11-12 | 2026-08-13 |
| Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients L-Arginine, Placebo - Cognition Disorders in Old Age, Cognitive and Behavioral Impairment | Phase 2 | Recruiting | German University in Cairo | 60 | 2025-08-27 | 2026-01-21 |
| Comparison Between Treatments of Oligohydramnios Sildenafil 25 MG, L-Arginine, 1000 Mg Oral Tablet - Oligohydramnios | Phase 2 | Unknown | Kafrelsheikh University | 40 | 2024-09-01 | 2025-08-21 |
| Arginine Replacement Therapy in COVID-19 Arginine Hydrochloride - COVID-19 | Phase 2 | Recruiting | Emory University | 21 | 2024-01-08 | 2026-04-15 |
| Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy. L-arginine, Placebo - Presbyvestibulopathy | Phase 2 | Withdrawn | Centro Universitario de Tonalá | 2023-05-02 | 2024-02-15 | |
| Immunonutrition for Diabetic Foot Ulcers Lovaza, L-Arginine Powder, Vitamin C - Diabetes Mellitus, Diabetic Peripheral Neuropathy | Phase 2 / Phase 3 | Terminated | Prisma Health-Midlands | 1 | 2023-02-08 | 2024-12-27 |
| Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis L-arginine, Placebo - Rheumatoid Arthritis | Phase 2 | Unknown | RenJi Hospital | 144 | 2021-01-01 | 2020-09-02 |
| L-arginine Study for Persistent Symptoms of Schizophrenia L-arginine, Sapropterin Dihydrochloride - Schizo Affective Disorder, Schizophrenia | Phase 2 | Withdrawn | University of Massachusetts, Worcester | 2019-09-11 | 2022-01-20 | |
| Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury Arginine, Placebo - Drug-Induced Nephropathy, Hypertension | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2018-10-23 | 2019-05-21 | |
| Efficacy of Aspirin and L-arginine in High Risk Preeclamptic L-arginine, Placebo (for L-arginine), acetylsalicylic acid - High Risk Pregnancy | Phase 2 | Suspended | University of Guadalajara | 82 | 2018-07-01 | 2020-11-27 |
| "Unifuzol®" in Patients With Peripheral Arterial Disease L-arginine 1.4% 500 ml, L-arginine 1.4% 250 ml + placebo 250 ml, Placebo solution - Peripheral Arterial Disease | Phase 2 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 360 | 2018-03-16 | 2020-01-31 |
| Use of Vasopressin Following the Fontan Operation Vasopressin, Normal Saline - Pleural Effusion, Single-ventricle | Phase 2 / Phase 3 | Completed | Wake Forest University Health Sciences | 12 | 2016-12-01 | 2024-10-24 |
| Arginine Therapy for Sickle Cell Disease Pain L-arginine, L-arginine Loading Dose, Placebo - Sickle Cell Disease, Vaso-occlusive Pain Episode | Phase 2 | Completed | Emory University | 108 | 2016-02-01 | 2023-09-06 |
| Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease Arginine, Arginine (Loading), Arginine (Continuous) - Sickle Cell Disease | Phase 1 / Phase 2 | Recruiting | Emory University | 21 | 2015-05-01 | 2026-07-29 |
| To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study Control toothpaste containing no anti-cavity ingredients, Experimental toothpaste containing fluoride and amino acid (arginine), Fluoride toothpaste containing fluoride as the anti-cavity ingredient - Dental Caries | Phase 2 | Withdrawn | Colgate Palmolive | 2015-04-01 | 2022-09-27 | |
| Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation Standard of care ADT + (HMB + arginine + glutamine), Standard of care ADT - Prostate Cancer | Phase 2 | Completed | Medical College of Wisconsin | 48 | 2014-03-01 | 2023-09-22 |
| L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels L-Arginine, Placebo - Asthma, Inflammation | Phase 2 | Completed | Nicholas Kenyon | 54 | 2013-08-01 | 2020-04-21 |
| L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome L-Arginine - MELAS Syndrome | Phase 2 | Completed | The Hospital for Sick Children | 7 | 2012-05-01 | 2013-12-17 |
| L-Arginine, Vascular Response and Mechanisms L-Arginine, Placebo Supplement - Hypertension, Diabetes | Phase 2 | Completed | Brigham and Women's Hospital | 25 | 2012-04-01 | 2016-07-28 |
Showing 20 of 35. Sign in to see all of them.
Anemia, Sickle Cell (5) · Diabetes Mellitus (3) · Asthma (2) · Cognitive Dysfunction (2) · Hypertension (2) · Inflammation (2) · Prostatic Neoplasms (2) · Alcoholism (1) · Alzheimer Disease (1) · Amino Acid Metabolism, Inborn Errors (1) · Anemia (1) · Argininosuccinic Aciduria (1) · Arterial Occlusive Diseases (1) · Arthritis, Rheumatoid (1) · COVID-19 (1)
Emory University (3) · UCSF Benioff Children's Hospital Oakland (3) · The Hospital for Sick Children (2) · University of Massachusetts, Worcester (2) · Wake Forest University Health Sciences (2) · Ain Shams University (1) · Brendan Lee (1) · Brigham and Women's Hospital (1) · Centro Universitario de Tonalá (1) · Colgate Palmolive (1) · David K Carroll (1) · German University in Cairo (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1) · Instituto de Oncología Ángel H. Roffo (1) · Joshua Palmer (1)
United States (21) · Egypt (3) · Canada (2) · Mexico (2) · China (1) · Germany (1) · Indonesia (1) · Russia (1)
Claudia Morris, MD (2) · Alfredo H Navigante, MD, Phd (1) · Bennet Amaechi, PhD, DDS (1) · Brendan Lee, MD, PhD (1) · Carlton Dampier, MD (1) · Carolyn Bigelow, MD (1) · Claudia R Morris, MD (1) · Claudia R. Morris, MD (1) · Cynthia Rutherford, MD (1) · Dalia S Zolfakar, PHD (1) · Elizabeth R DeGrush, DO (1) · Farhad Danesh (1) · Felix Ratjen, MD (1) · GHada A. Saleh, MRCPCH (1) · Ingrid Tein, MD (1)
PMID 32384147, PMID 42549972, PMID 17636753, PMID 18545693, PMID 23333044, PMID 23645695, PMID 25861285, PMID 25993630, PMID 32497023, PMID 32881886, PMID 34724240, PMID 36115980, PMID 37319354, PMID 38527291, PMID 38775255, PMID 40270092
K24AT009893 (2), P30CA016672 (1), R01HL105573 (1), U10CA081851 (1), U54HD061221 (1), U54HL070587 (1), UL1RR024146 (1)